348 related articles for article (PubMed ID: 26800435)
1. Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus.
Tavakolpour S
Dermatol Ther; 2016 Sep; 29(5):299. PubMed ID: 26800435
[No Abstract] [Full Text] [Related]
2. Dupilumab (Dupixent) for moderate to severe atopic dermatitis.
Med Lett Drugs Ther; 2017 Apr; 59(1519):64-66. PubMed ID: 28419072
[No Abstract] [Full Text] [Related]
3. The beginning of biological treatment era in the atopic dermatitis management.
D'erme AM
Dermatol Ther; 2016 May; 29(3):208-9. PubMed ID: 26331894
[No Abstract] [Full Text] [Related]
4. Remittive effect of Dupilumab in atopic dermatitis.
Treister AD; Lio PA
Dermatol Ther; 2018 Nov; 31(6):e12711. PubMed ID: 30253014
[No Abstract] [Full Text] [Related]
5. Monoclonal antibodies for the treatment of atopic dermatitis.
Renert-Yuval Y; Guttman-Yassky E
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
[TBL] [Abstract][Full Text] [Related]
6. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J
Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
[No Abstract] [Full Text] [Related]
7. Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis.
Fowler E; Rosen J; Lev-Tov H; Yosipovitch G
Acta Derm Venereol; 2019 Sep; 99(10):899-900. PubMed ID: 31037315
[No Abstract] [Full Text] [Related]
8. Dupilumab for treatment of atopic dermatitis.
Seegräber M; Srour J; Walter A; Knop M; Wollenberg A
Expert Rev Clin Pharmacol; 2018 May; 11(5):467-474. PubMed ID: 29557246
[TBL] [Abstract][Full Text] [Related]
9. [Key-studies on dupilumab].
Velter C
Ann Dermatol Venereol; 2018; 145(8-9):532-538. PubMed ID: 30093077
[No Abstract] [Full Text] [Related]
10. A retrospective review of dupilumab for atopic dermatitis patients with allergic contact dermatitis.
Chipalkatti N; Lee N; Zancanaro P; Dumont N; Kachuk C; Rosmarin D
J Am Acad Dermatol; 2019 Apr; 80(4):1166-1167. PubMed ID: 30630024
[No Abstract] [Full Text] [Related]
11. Recall dermatitis at patch test sites in an atopic dermatitis patient treated with dupilumab.
Collantes-Rodríguez C; Jiménez-Gallo D; Ossorio-García L; Villegas-Romero I; Linares-Barrios M
Contact Dermatitis; 2019 Jan; 80(1):69-70. PubMed ID: 30334260
[No Abstract] [Full Text] [Related]
12. The show must go on: an update on clinical experiences and clinical studies on novel pharmaceutical developments for the treatment of atopic dermatitis.
Honstein T; Werfel T
Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):386-394. PubMed ID: 32452891
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR
N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719
[TBL] [Abstract][Full Text] [Related]
15. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers.
He H; Olesen CM; Pavel AB; Clausen ML; Wu J; Estrada Y; Zhang N; Agner T; Guttman-Yassky E
Front Immunol; 2020; 11():1768. PubMed ID: 32849633
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab, A Monoclonal Antibody for Atopic Dermatitis: A Review of Current Literature.
Blakely K; Gooderham M; Papp K
Skin Therapy Lett; 2016 Mar; 21(2):1-5. PubMed ID: 27223113
[TBL] [Abstract][Full Text] [Related]
17. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL; Bieber T; Guttman-Yassky E; Beck LA; Blauvelt A; Cork MJ; Silverberg JI; Deleuran M; Kataoka Y; Lacour JP; Kingo K; Worm M; Poulin Y; Wollenberg A; Soo Y; Graham NM; Pirozzi G; Akinlade B; Staudinger H; Mastey V; Eckert L; Gadkari A; Stahl N; Yancopoulos GD; Ardeleanu M;
N Engl J Med; 2016 Dec; 375(24):2335-2348. PubMed ID: 27690741
[TBL] [Abstract][Full Text] [Related]
18. [Triderm in the treatment of atopic dermatitis].
Kaliuzhnaia DD
Voen Med Zh; 1999 Feb; 320(2):53-5. PubMed ID: 10330896
[No Abstract] [Full Text] [Related]
19. A Therapeutic Renaissance - Emerging Treatments for Atopic Dermatitis.
Na CH; Baghoomian W; Simpson EL
Acta Derm Venereol; 2020 Jun; 100(12):adv00165. PubMed ID: 32419031
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
